Bioventrix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioventrix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioventrix Today - Breaking & Trending Today

EQS-News: Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix®

EQS-News: Andera Partners / Key word(s): Financing Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix® 13.04.2023 / 12:45 CET/CEST The issuer ....

United States , France General , Bihua Chen , Andera Croissance , Raphael Wisniewski , Jim Dillon , Drug Administration , Bioventrix Inc , Taglich Brothers Inc , Mc Services , Access Program , Distribution Services , Andera Life Sciences , Bandera Co , Andera Partners , Cormorant Asset Management , Squarepoint Capital , Bioventrix Premarket Approval , Expanded Access Program , Investigational Device , Andera Midcap , Andera Expansion , Andera Co Invest , Andera Acto , Andera Infra , Bien Commun Advisory ,

World-Renowned Cardiologists and Cardiac Surgeons to Feature Innovative Heart Failure Therapies at Technology and Heart Failure Therapeutics, March 20-22, 2023

/PRNewswire/ WHAT: Innovative therapeutic approaches for left ventricular restoration for patients with Heart Failure with Reduced Ejection Fraction (HFrEF).. ....

United States , Ori Ben Yehuda Bioventrix Inc , Investigational Use , Michael Pfeiffer Penn State Hershey Medical Center , Bioventrix Inc , Heart Failure , Reduced Ejection Fraction , Left Ventricular , Less Invasive Ventricular Enhancement , Bioventrix Revivent , Transcatheter Ventricular Enhancement , Boston Seaport District , Cardiac Surgeons , Guideline Directed Medical Therapy , Left Ventricle , Interventional Heart Failure , Next Frontier , Lunch Symposium , Westin Boston Seaport District , Concourse Level , Grand Ballroom , Ori Ben Yehuda , Joggy George , Texas Heart Specialists , Patrick Klein , San Antonius Hospital ,

New Study Demonstrates Accurate Measurement of Left Ventricular Function Following Treatment with BioVentrix Revivent TC® Therapy

/PRNewswire/ BioVentrix®, Inc., a privately held medical device company developing less invasive therapies to directly treat the dilated left ventricle. ....

United States , Investigational Use , Bioventrix Inc , Drug Administration , Access Program , Inward Displacement Approach Assesses , Left Ventricular Device , Clinical Medicine , Inward Displacement , Novel Approach , Measuring Left Ventricular , Undergoing Bioventrix , Bioventrix Revivent , Rishi Puri , Structural Interventional Cardiologist , Cleveland Clinic , Left Ventricular Restoration , Ori Ben Yehuda , Chief Medical Officer , Less Invasive Ventricular Enhancement , Expanded Access Program , Premarket Approval , Investigational Use Only ,

BioVentrix® Names Dr. Ori Ben-Yehuda as Chief Medical Officer

/PRNewswire/ BioVentrix®, Inc., a privately held medical device company focused on the development of less invasive therapies to directly treat the dilated. ....

United States , San Diego , Jim Dillon , University Of California , Investigational Use , Gilead Sciences , Drug Administration , Journal Of The Heart Team , Patient Care Experience To Senior Management Team , Bioventrix Inc , Department Of Medicine Teaching , Clinical Trials Center , Cardiovascular Research Foundation , Access Program , Brings Extensive Clinical Trial , Patient Care Experience , Senior Management , Ori Ben Yehuda , Chief Medical Officer , Premarket Approval , Coronary Artery Disease , Deputy Editor , Structural Heart , Iheart Team , Executive Director , Vice President ,

FDA Agrees to Expanded Access Program for the BioVentrix® Revivent TC® System for the Treatment of Ischemic Heart Failure

/PRNewswire/ BioVentrix®, Inc., a privately held medical device company focused on the development of less invasive therapies to directly treat the dilated. ....

New York , United States , Jerryd Estep , Jim Dillon , Prnewswire Bioventrix , Population Health Sciences , Icahn School Of Medicine At Mount Sinai , Bioventrix Inc , Drug Administration , Investigational Use Only , Access Program , Provide Opportunity , Treat Additional Patients , Expanded Access Program , Less Invasive Ventricular Enhancement , Bioventrix Revivent , Co Principal Investigator , Academic Affairs , Mount Sinai Heart Health System , Icahn School , Mount Sinai , Cleveland Clinic , Premarket Approval , Investigational Use Only In The United , Health Care Amp Hospitals , Medical Pharmaceuticals ,